[{"id":"5da4f947-0bd6-47b4-9efc-8843839a953e","acronym":"","url":"https://clinicaltrials.gov/study/NCT02950064","created_at":"2021-01-18T14:29:20.113Z","updated_at":"2024-07-02T16:37:03.883Z","phase":"Phase 1","brief_title":"A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations","source_id_and_acronym":"NCT02950064","lead_sponsor":"Placon Therapeutics","biomarkers":" BRCA • CHEK2 • RAD51D","pipe":" | ","alterations":" BRCA mutation","tags":["BRCA • CHEK2 • RAD51D"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BTP-114"],"overall_status":"Unknown status","enrollment":" Enrollment 95","initiation":"Initiation: 09/01/2016","start_date":" 09/01/2016","primary_txt":" Primary completion: 04/01/2020","primary_completion_date":" 04/01/2020","study_txt":" Completion: 08/01/2020","study_completion_date":" 08/01/2020","last_update_posted":"2019-01-14"}]